Skip to main content
Erschienen in: Netherlands Heart Journal 1/2024

Open Access 12.12.2023 | Editor’s Comment

‘An ounce of prevention is worth a pound of cure’

verfasst von: Ruud F. Spee, Hareld M. Kemps, Tom Vromen

Erschienen in: Netherlands Heart Journal | Ausgabe 1/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Benjamin Franklin famously advised fire-threatened Philadelphians in 1736 that ‘An ounce of prevention is worth a pound of cure.’ Looking even further back in history, a famous Chinese proverb states that inferior doctors cure the disease, mediocre doctors treat the impending disease and superior doctors prevent the disease. This tells us that prevention was always an important theme in human history. The beginning of a new year is the time for looking back, to evaluate the lessons learned and set good intentions for the coming year. Citing the title of the article by Kupper et al. in this issue: it is time for a little less conversation and more action.
In this special issue we focus on current perspectives and advancements in secondary prevention and cardiac rehabilitation (CR). We think it is important to stress the fact that all contributions are of Dutch origin. This shows the strength and quality in the field of secondary prevention and CR. Dutch researchers are able to set the standard for Europe. In line with this ambition, the working group of cardiovascular prevention and rehabilitation (CPH) in collaboration with the working group Cardiology and Sport have composed a fellowship (in Dutch aandachtsgebied) Preventive Cardiology based on the curriculum of the European Association of Preventive Cardiology (EAPC) [1]. This will consist of three pillars: prevention, cardiac rehabilitation and sports cardiology. In the quickly evolving and complex field of Preventive Cardiology it is important to educate the future leaders in this field.
However, we all have a duty in prevention and it does not have to take a lot of time. A very brief advice (VBA) on lifestyle given by a cardiologist can already make an impact for our patients as stated by IJzerman et al. in this issue [2].
Psychosocial factors often underlie an unhealthy lifestyle. In our daily practice, this is often overlooked and standardised screening is lacking. Kupper et al. provide practical advice and a framework for future studies [3].
As our population in the consultation room will only get older, it is important to evaluate the benefits and harms of secondary prevention in this specific population. Van Trier et al. quantified the effect of implementing different guidelines in patients over 70, expressed as the potential individual benefit in gain of event-free years [4].
The image of most caregivers and patients about CR is still a group of old men cycling in a small gym with a physiotherapist on the side telling them what to do. In contrast, with advancements in medical technology, personalised treatment plans tailored to individual patients’ needs have become more opportune. This approach allows healthcare professionals to optimise medication regimens and lifestyle modifications, leading to better outcomes. In this respect, for both healthcare professionals and patients, it is crucial to receive regular and accurate feedback on lifestyle behaviour. Goevaerts et al. evaluated a comprehensive app, which can help caregivers and patients to achieve personalised lifestyle goals [5].
Furthermore, the integration of remote patient monitoring has revolutionised the delivery of CR. Patients can easily access information and resources from the comfort of their homes, and healthcare providers can remotely monitor crucial health indicators and provide timely guidance and support. This has resulted in enhanced patient engagement and improved adherence to treatment plans. Still, several barriers have to be taken before telerehabilitation is widely implemented in the daily practice of CR. Brouwers et al. provide us guidance to take the next steps [6].
New populations are appearing in CR, such as patients with obesity and/or atrial fibrillation. This topic was studied in the Opticare XL study. Short-term results were positive but in the long term effects did not last. Are we on the right track for these patients? Den Uijl et al. demonstrate which lessons can be learned [7].
In the paper by Van Til et al., [8] we can appreciate the importance of collaboration in CR when it comes to screening for cognitive impairment after cardiac arrest. Barriers are solvable but a few hurdles have to be taken.
Recently, Zorginstituut Nederland stated that CR has insufficient scientific evidence to be prescribed in patients with stable angina pectoris [9], despite a class Ia in national and international guidelines [10]. One should wonder why are we treating patients with stable angina pectoris, peripheral artery disease or a cerebrovascular accident differently with respect to cardiovascular risk management and rehabilitation programs, when the underlying cause is atherosclerosis in the vast majority with the same underlying risk factors. In addition, ‘presumed absence of evidence does not mean evidence of absence’ [11]. Heutinck et al. provide an overview of the physiological mechanisms underlying the potential beneficial effects of exercise-based CR as a first-line treatment for angina pectoris [12]. The ongoing PRO-FIT trial may provide answers for contemporary knowledge gaps in this area [13].
Moreover, in 2024 an update of the 2011 multidisciplinary CR guideline is expected, which will help caregivers in CR to provide care according to the most actual scientific standard.
In summary, secondary prevention and cardiac rehabilitation have evolved significantly. With the advancements in technology and a holistic approach to patient care, these interventions have become more effective and accessible, leading to improved cardiovascular outcomes and better quality of life for individuals recovering from cardiac events.
We wish the reader all the best for 2024, with exciting times in secondary prevention and CR ahead of us. Let’s hope that the upcoming government will listen to their American historical counterpart Franklin and aim high for prevention.

Conflict of interest

R.F. Spee, H.M. Kemps and T. Vromen declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Wilhelm M, Abreu A, Adami PE, et al. EAPC core curriculum for preventive cardiology. Eur J Prev Card. 2022;29:251–74.CrossRef Wilhelm M, Abreu A, Adami PE, et al. EAPC core curriculum for preventive cardiology. Eur J Prev Card. 2022;29:251–74.CrossRef
5.
Zurück zum Zitat Goevaerts WF, Van Limpt NCC, Lu Y, et al. Evaluation of an application for the self-assessment of lifestyle behaviour in cardiac patients. Neth Heart J. 2024;32 DOI : 10.1007/s12471-023-01835-7 Goevaerts WF, Van Limpt NCC, Lu Y, et al. Evaluation of an application for the self-assessment of lifestyle behaviour in cardiac patients. Neth Heart J. 2024;32 DOI : 10.1007/s12471-023-01835-7
8.
Zurück zum Zitat Van Til J, Hemels M, Hofmeijer J. Cognitive screening and rehabilitation after cardiac arrest: only few hurdles to take. Neth Heart J. 2024;32 DOI : 10.1007/s12471-023-01838-4. Van Til J, Hemels M, Hofmeijer J. Cognitive screening and rehabilitation after cardiac arrest: only few hurdles to take. Neth Heart J. 2024;32 DOI : 10.1007/s12471-023-01838-4.
10.
Zurück zum Zitat The ESC Scientific Document Group, Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.CrossRef The ESC Scientific Document Group, Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.CrossRef
11.
Zurück zum Zitat ‘Absence of Evidence Is Not Evidence of Absence’. Quote Investigator. 2019-09-17. Retrieved 2021-10-23. ‘Absence of Evidence Is Not Evidence of Absence’. Quote Investigator. 2019-09-17. Retrieved 2021-10-23.
13.
Zurück zum Zitat The PRO-FIT Research Group, Heutinck JM, De Koning IA, Vromen T, et al. Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial. BMC Cardiovasc Disord. 2023;231:238. https://doi.org/10.1186/s12872-023-03266-z.CrossRef The PRO-FIT Research Group, Heutinck JM, De Koning IA, Vromen T, et al. Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial. BMC Cardiovasc Disord. 2023;231:238. https://​doi.​org/​10.​1186/​s12872-023-03266-z.CrossRef
Metadaten
Titel
‘An ounce of prevention is worth a pound of cure’
verfasst von
Ruud F. Spee
Hareld M. Kemps
Tom Vromen
Publikationsdatum
12.12.2023
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 1/2024
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-023-01839-3

Weitere Artikel der Ausgabe 1/2024

Netherlands Heart Journal 1/2024 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.